Literature DB >> 17020682

[Fragility non-spinal fractures in a cohort of 5,201 women aged 65 years and older during a 3-year follow-up].

Fernando Marín1, Jesús González-Macías, Rafael Moya, Consuelo Onrubia, Carmen Cancelo, Salvador Alvarez, Juan José Montero, Francisco Gómez, Cristina Carbonell, Joan Vila, Adolfo Díez-Pérez.   

Abstract

BACKGROUND AND
OBJECTIVE: Low-trauma non-spinal fractures are a growing source of morbidity and mortality in the elderly. We aimed to evaluate the overall incidence of low-trauma non-spinal fractures and of the main skeletal sites in a cohort of women from Spain. PATIENTS AND
METHOD: A total of 5,201 women, aged 65 or older, were enrolled in a 3-year cohort study by non-probabilistic sampling of consecutive cases in 58 primary care centers in Spain, with 6-month visits. All radiological or surgically confirmed low trauma non-spinal fractures were collected.
RESULTS: 311 women (6.0%) sustained a total of 363 fractures after a 3.01-year median follow-up, and 14,999 women-year. The incidence rate of overall non-spinal fractures was 2,420 cases per 100,000 women-year. The incidence rates of hip, forearm and humeral fractures were 887,369 and 333 cases/100,000 women-year respectively.
CONCLUSIONS: Low-trauma non-spinal fractures are highly incident in Spain in women aged 65 years or older, similar to other western countries.

Entities:  

Mesh:

Year:  2006        PMID: 17020682     DOI: 10.1157/13092764

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  "Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study".

Authors:  Aina Pagès-Castellà; Cristina Carbonell-Abella; Francesc Fina Avilés; Maite Alzamora; Jose Miguel Baena-Díez; Daniel Martínez Laguna; Xavier Nogués; Adolfo Díez-Pérez; Daniel Prieto-Alhambra
Journal:  BMC Musculoskelet Disord       Date:  2012-05-28       Impact factor: 2.362

2.  Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain.

Authors:  Josep Darbà; Nuria Pérez-Álvarez; Lisette Kaskens; Susana Holgado-Pérez; Jill Racketa; Javier Rejas
Journal:  Clinicoecon Outcomes Res       Date:  2013-07-05

3.  Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain.

Authors:  Josep Darbà; Lisette Kaskens; Francesc Sorio Vilela; Mickael Lothgren
Journal:  Clinicoecon Outcomes Res       Date:  2015-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.